Last $31.73 USD
Change Today -0.09 / -0.28%
Volume 175.7K
BRLI On Other Exchanges
Symbol
Exchange
Berlin
As of 5:20 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

bio-reference labs inc (BRLI) Snapshot

Open
$31.82
Previous Close
$31.82
Day High
$32.26
Day Low
$31.55
52 Week High
08/27/14 - $34.00
52 Week Low
01/6/14 - $24.13
Market Cap
879.8M
Average Volume 10 Days
336.9K
EPS TTM
$1.99
Shares Outstanding
27.7M
EX-Date
--
P/E TM
15.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIO-REFERENCE LABS INC (BRLI)

bio-reference labs inc (BRLI) Related Bloomberg News

View More Bloomberg News

bio-reference labs inc (BRLI) Related Businessweek News

No Related Businessweek News Found

bio-reference labs inc (BRLI) Details

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in New Jersey, New York, Maryland, Massachusetts, Texas, and Ohio. The company offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. It focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

bio-reference labs inc (BRLI) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $1.2M
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $449.2K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $449.9K
Compensation as of Fiscal Year 2013.

bio-reference labs inc (BRLI) Key Developments

Bio-Reference Laboratories Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended October 31, 2014; Provides Earnings Guidance for the Full Year of Fiscal 2015

Bio-Reference Laboratories Inc. reported unaudited earnings results for the fourth quarter and full year ended October 31, 2014. For the quarter, net revenues were $227,594,000 against $192,219,000 a year ago. Operating income was $30,795,000 against $20,447,000 a year ago. Income before taxes was $30,115,000 against $19,773,000 a year ago. Net income was $18,281,000 against $11,120,000 a year ago. Income per diluted share was $0.66 against $0.40 a year ago. These earnings were decreased by $0.03 due to unexpected legal fees incurred by filing invalidation petitions with United States Patent and Trade Office against Myriad Genetics, which expenses did not anticipate when it originally gave its guidance. For the full year, net revenues were $832,282,000 against $715,354,000 a year ago. Operating income was $83,425,000 against $81,973,000 a year ago. Income before taxes was $80,967,000 against $81,097,000 a year ago. Net income was $46,758,000 against $45,825,000 a year ago. Income per diluted share was $1.68 against $1.65 a year ago. The company expects in fiscal 2015 to see a greater than 10% increase in net revenues and a 20% increase in net income over its fiscal 2014 results.

Bio-Reference Laboratories Inc. to Report Q4, 2014 Results on Dec 18, 2014

Bio-Reference Laboratories Inc. announced that they will report Q4, 2014 results on Dec 18, 2014

Bio-Reference Laboratories Inc., Q4 2014 Earnings Call, Dec 18, 2014

Bio-Reference Laboratories Inc., Q4 2014 Earnings Call, Dec 18, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $31.73 USD -0.09

BRLI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $21.53 USD -0.80
Genomic Health Inc $32.50 USD +0.06
Myriad Genetics Inc $36.65 USD +0.15
RadNet Inc $9.61 USD +0.20
Sequenom Inc $3.73 USD +0.14
View Industry Companies
 

Industry Analysis

BRLI

Industry Average

Valuation BRLI Industry Range
Price/Earnings 19.0x
Price/Sales 1.1x
Price/Book 2.8x
Price/Cash Flow 18.9x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit www.bioreference.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.